Beatrijs Wokke

8PUBLICATIONS
20CO-AUTHORS
Infant and child healthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyNeurosciences not elsewhere classifiedCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 03, 2026
Update on the Incidence of Paediatric Multiple Sclerosis, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Other Acquired Demyelinating Syndromes in the Netherlands, 2017-2025, Including the COVID-19 Pandemic.

|Feb 16, 2026
Integrin β1 Demarks Precursors of Brain-Residing Antibody-Secreting Cells in Multiple Sclerosis.

Kirsten L Kuiper, Laurens Bogers, Jasper Rip

|Sep 23, 2025
Aggressive treatment of early acute focal inflammatory activity to extend the window for BTK inhibition in multiple sclerosis.

Joost Smolders, Ide Smets, Beatrijs Wokke

|Nov 04, 2024
Serum neurofilament light and glial fibrillary acidic protein levels are not associated with wearing-off symptoms in natalizumab-treated multiple sclerosis patients.

Alyssa A Toorop, Mark Hj Wessels, Lynn Boonkamp

|Jul 16, 2024
Putative benefits of vitamin D supplements in multiple sclerosis out of reach due to sample size.

Cato E A Corsten, Beatrijs H A Wokke, Joost Smolders

|Jun 11, 2024
Benefits of early highly effective versus escalation treatment strategies in relapsing multiple sclerosis estimated using a treatment-sequence model.

Ide Smets, Matthijs Versteegh, Simone Huygens

Pageof 2

Frequent Collaborators

6 joint publications

Joost Smolders

5 joint publications

Ide Smets

2 joint publications

Cato E A Corsten

1 joint publications

Sandy Molenaar